Overview

Effect of Adding Magnesium Sulphate in Pericapsular Nerve Group Block

Status:
Not yet recruiting
Trial end date:
2025-03-30
Target enrollment:
Participant gender:
Summary
Our aim will be to compare the analgesic efficacy and safety of magnesium sulphate as an adjuvant to bupivacaine in pericapsular nerve group block in Hip joint surgeries. - Our primary outcome of the study: total amount of postoperative morphine consumption in the first 24h postoperative. - Our secondary outcome of the study: mean arterial blood pressure, heart rate, respiratory rate, adverse effects, block related complication, sedation score (by Ramsay sedation scale) and pain score (by Visual Analog Scale)
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Assiut University
Treatments:
Bupivacaine
Magnesium Sulfate